Risperidone ISM

DRUG2 trials

Sponsors

Rovi Pharmaceuticals Laboratories

Conditions

Schizophrenia

Phase 2

Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia

CompletedNCT02086786

Rovi Pharmaceuticals LaboratoriesSchizophrenia

Start: 2014-03-31End: 2015-03-31Updated: 2017-07-13

Unknown Phase

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

CompletedNCT05480046

Rovi Pharmaceuticals LaboratoriesSchizophrenia

Start: 2022-10-18End: 2025-03-13Updated: 2025-12-05